Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: a phase I clinical trial

BACKGROUNDS: Alzheimer’s disease is the most common cause of dementia, and currently, there is no disease-modifying treatment. Favorable functional outcomes and reduction of amyloid levels were observed following transplantation of mesenchymal stem cells (MSCs) in animal studies. OBJECTIVES: We cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Jin, Cho, Kyung Rae, Jang, Hyemin, Lee, Na Kyung, Jung, Young Hee, Kim, Jun Pyo, Lee, Jung Il, Chang, Jong Wook, Park, Seongbeom, Kim, Sung Tae, Moon, Seung Whan, Seo, Sang Won, Choi, Soo Jin, Na, Duk L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439008/
https://www.ncbi.nlm.nih.gov/pubmed/34521461
http://dx.doi.org/10.1186/s13195-021-00897-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439008/
https://www.ncbi.nlm.nih.gov/pubmed/34521461
http://dx.doi.org/10.1186/s13195-021-00897-2

Ejemplares similares